title

JAMA Cardiology Author Interviews

The JAMA Network

6
Followers
9
Plays
JAMA Cardiology Author Interviews
JAMA Cardiology Author Interviews

JAMA Cardiology Author Interviews

The JAMA Network

6
Followers
9
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide.JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Latest Episodes

Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease

Interview with Scott David Solomon, MD, and Stephen Yishu Wang, BS, authors of Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study, and Edward P. Havranek, MD, author of The Influence of Social and Economic Factors on Heart Disease

11 MIN2 w ago
Comments
Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

24 MINSEP 25
Comments
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Interview with Paaladinesh Thavendiranathan, MD, MSc, FRCPC, FASE, author of Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis

25 MINAUG 21
Comments
Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients

28 MINJUL 17
Comments
Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

Coronary Anatomical Complexity and Clinical Outcomes After Percutaneous or Surgical Revascularization

Interview with Stephen W. Waldo, MD, author of Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

9 MINJUN 26
Comments
Coronary Anatomical Complexity and Clinical Outcomes After Percutaneous or Surgical Revascularization

Screening for Familial Hypercholesterolemia

Interview with Amit Khera, MD, MSc, author of Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors and and Stephen Daniels, MD, author of Screening for Familial Hypercholesterolemia.

23 MINMAY 22
Comments
Screening for Familial Hypercholesterolemia

Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens

18 MINAPR 24
Comments
Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure

Interview with Scott David. Solomon, MD, author of Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

18 MINMAR 27
Comments
Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure

Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

Interview with Paul A Heidenreich, MD, MS, author of Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

19 MINFEB 14
Comments
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

Association of Mortality With High Levels of Physical Activity and Coronary Artery Calcification

Interview with Benjamin D. Levine, author of Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification

24 MINJAN 31
Comments
Association of Mortality With High Levels of Physical Activity and Coronary Artery Calcification

Latest Episodes

Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease

Interview with Scott David Solomon, MD, and Stephen Yishu Wang, BS, authors of Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study, and Edward P. Havranek, MD, author of The Influence of Social and Economic Factors on Heart Disease

11 MIN2 w ago
Comments
Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

24 MINSEP 25
Comments
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Interview with Paaladinesh Thavendiranathan, MD, MSc, FRCPC, FASE, author of Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis

25 MINAUG 21
Comments
Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients

28 MINJUL 17
Comments
Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

Coronary Anatomical Complexity and Clinical Outcomes After Percutaneous or Surgical Revascularization

Interview with Stephen W. Waldo, MD, author of Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

9 MINJUN 26
Comments
Coronary Anatomical Complexity and Clinical Outcomes After Percutaneous or Surgical Revascularization

Screening for Familial Hypercholesterolemia

Interview with Amit Khera, MD, MSc, author of Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors and and Stephen Daniels, MD, author of Screening for Familial Hypercholesterolemia.

23 MINMAY 22
Comments
Screening for Familial Hypercholesterolemia

Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens

18 MINAPR 24
Comments
Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure

Interview with Scott David. Solomon, MD, author of Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

18 MINMAR 27
Comments
Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure

Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

Interview with Paul A Heidenreich, MD, MS, author of Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

19 MINFEB 14
Comments
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

Association of Mortality With High Levels of Physical Activity and Coronary Artery Calcification

Interview with Benjamin D. Levine, author of Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification

24 MINJAN 31
Comments
Association of Mortality With High Levels of Physical Activity and Coronary Artery Calcification